Malignancy and rheumatoid arthritis

被引:32
|
作者
Askling J. [1 ]
机构
[1] Clinical Epidemiology Unit M9:01, Department of Medicine Solna, Karolinska University Hospital Solna
关键词
Rheumatoid Arthritis; Cancer Risk; Abatacept; Cancer Occurrence; Rheumatoid Arthritis Treatment;
D O I
10.1007/s11926-007-0067-1
中图分类号
学科分类号
摘要
The occurrence of cancer is not an infrequent event in patients with rheumatoid arthritis (RA). Indeed, following diagnosis of RA at a typical age (55 years), one in five patients will be diagnosed with cancer. In the vast majority of such cases, the cancer has nothing to do with RA or its treatment; rather, it represents the "background" risk applicable to all humans. In some cases, the cancer occurs as a result of factors also associated with the risk of developing RA (eg, smoking), even though no direct link exists between the cancer and the RA. In a fraction of cases, however, the cancer is causally associated with the RA disease or its treatments. This review summarizes our current understanding of the occurrence of cancer in RA, possible links to RA disease and to traditional and newer RA treatments. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:421 / 426
页数:5
相关论文
共 50 条
  • [1] Malignancy and biologic therapy in rheumatoid arthritis
    Askling, Johan
    Bongartz, Tim
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 334 - 339
  • [2] Rheumatoid arthritis mimicking an intracranial malignancy
    Kim Rijkers
    Alida Postma
    Robert Riedl
    Olaf Schijns
    Acta Neurochirurgica, 2014, 156 : 427 - 428
  • [3] Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy
    Kunishita, Yosuke
    Ichikawa, Kento
    Uzawa, Yuji
    Mitsuhashi, Masaki
    Yoshioka, Yuji
    Okubo, Tadanobu
    Nagaoka, Shouhei
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2023, 15
  • [4] Incidence of malignancy in Japanese patients with rheumatoid arthritis
    Toru Yamada
    Ayako Nakajima
    Eisuke Inoue
    Eiichi Tanaka
    Atsuo Taniguchi
    Shigeki Momohara
    Hisashi Yamanaka
    Rheumatology International, 2011, 31 : 1487 - 1492
  • [5] The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis
    Lee, Hwajeong
    YONSEI MEDICAL JOURNAL, 2019, 60 (02) : 223 - 229
  • [6] Incidence of malignancy in Japanese patients with rheumatoid arthritis
    Yamada, Toru
    Nakajima, Ayako
    Inoue, Eisuke
    Tanaka, Eiichi
    Taniguchi, Atsuo
    Momohara, Shigeki
    Yamanaka, Hisashi
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (11) : 1487 - 1492
  • [7] Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis
    Teresa A. Simon
    Adam Thompson
    Kunal K. Gandhi
    Marc C. Hochberg
    Samy Suissa
    Arthritis Research & Therapy, 17
  • [8] Pharmacologic Immunomodulation and Cutaneous Malignancy in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis
    Krathen, Michael S.
    Gottlieb, Alice B.
    Mease, Philip J.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) : 2205 - 2215
  • [9] Mortality and Incidence of Malignancy in Korean Patients with Rheumatoid Arthritis
    Kim, Yun Jung
    Shim, Jee-Seon
    Choi, Chan-Bum
    Bae, Sang-Cheol
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (02) : 226 - 232
  • [10] Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis
    Wilton, Katelynn M.
    Matteson, Eric L.
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 333 - 347